Contrasting preload-dependent hemodynamic and neurohumoral effects of isomazole, a partial phosphodiesterase inhibitor and calcium sensitizer

Journal of Cardiac Failure

Volumn 3, Issue 4, 1997, Pages 277-286

  Van Der Ent, Martin ^a   Remme, Willem J ^a   Bartels, G Louis ^a   De Leeuw, Peter W ^b   Van Hoogenhuyze, Diederik C A ^a   Kruijssen, Dick A C M ^a  

^a Sticares Cardiovascular Research Foundation   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcium sensitization; Heart failure; Humans; Myocardial function; Neurohormones; Phosphodiesterase inhibitors

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARDIOTONIC AGENT; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; SULMAZOLE;

ADULT; AGED; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; HEART; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR RESISTANCE;

ADULT; AGED; CARDIOTONIC AGENTS; CORONARY CIRCULATION; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NEUROTRANSMITTER AGENTS; PHOSPHODIESTERASE INHIBITORS; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 0031298123     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90027-0     Document Type: Article

References (25)

1. Remme WJ: Vasodilator therapy without convertingenzyme inhibition in congestive heart failure: usefulness and limitations. Cardiovasc Drugs Ther 1989;3:375-396
2. Ruegg JC: Calcium regulation of muscle contractility: the molecular regulation mechanisms of contractility. Naturwissenschaften 1987;74:579-584
3. Remme WJ, van Hoogenhuyze D, Kruijssen HA, Pieper PG, Bruggeling WA: Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Cardiology 1992;80:132-142
4. Brower RW, Meij S, Serruys PW: A model of asynchronous left ventricular relaxation predicting the bi-exponential pressure decay. Cardiovasc Res 1983;17:482-488
5. Dodge HT: Determination of left ventricular volume and mass. Radiol Clin North Am 1971;9:459-467
6. Remme WJ, van den Berg R, Mantel M, Cox PH, Van Hoogenhuyze DCA, Krauss XH, Kruijssen HACM: Temporal relation of changes in regional coronary flow and myocardial lactate and nucleoside metabolism during pacinginduced ischemia. Am J Cardiol 1986;58:1188-1194
7. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH: Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:4-55
8. Van der Hoorn FAJ, Boomsma F, Man in't Veld AJ, Schalekamp MADH: Determination of catecholamines by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 1989;487:17-28
9. Derkx FHM, Tan-Tjiong L, Wenting GJ, Boomsma F, Man in't Veld AJ, Schalekamp MADH: Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983; 5:24-256
10. Lues I, Siegel R, Harting J: Effect of isomazole on the responsiveness to calcium of the contractile elements in skinned cardiac muscle fibres of various species. Eur J Pharmacol 1988;146:145-153
11. Ruegg JC, Morano I: Calcium-sensitivity modulation of cardiac myofibrillar proteins. J Cardiovasc Pharmacol 1989;14(suppl. 3):S20-S23
12. Bethke T, Klimkiewicz A, Kohl C: Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts. J Cardiovasc Pharmacol 1991;18:386-397
13. Imai N, Liang CS, Stone CK: Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure. J Pharmacol Exp Ther 1987;241: 20-26
14. Tuininga YS, van Veldhuisen DJ, Crijns HJ: Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failure. J Cardiovasc Pharmacol 1995;25:81-86
15. Remme WJ, Kruijssen DACM, van Hoogenhuyze DCA, Barters GL, Storm CJ, de Leeuw PW: Hemodynamic, neurohumoral and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. J Cardiovasc Pharmacol 1994;24:730-739
16. Remme WJ: Inotropic agents for heart failure: what if digoxin increases mortality? Br Heart J 1994;72(suppl.): S92-S99
17. ++ sensitivity of contractile proteins. Circulation 1986;73:III78-III84
18. Hajjar RJ, Gwathmey JK: Calcium-sensitizing inotropic agents in the treatment of heart failure: a critical view. Cardiovasc Drugs Ther 1991;5:961-965
19. Hagemeijer F, Brand HJ, van Mechelen R: Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:571-576
20. Viquerat CE. Kereiakes D, Morris DL: Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure. J Am Coll Cardiol 1985;5:326-332
21. Monrad ES, Baim DS, Smith HS, Lanoue A, Braunwald E, Grossman W: Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985;71:972-979
22. Colucci WS, Alexander RW, Williams GH: Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med 1981;305:185-190
23. Packer M, Meller J, Medina N, Yushak M, Gorlin R: Determinants of drug response in severe chronic heart failure: 1. Activation of vasoconstrictor forces during vasodilator therapy. Circulation 1981;64:506-514
24. Bates ER, Shenker Y, Grekin RJ: The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986;73:1155-1161
25. Benedict CR, Johnstone DE, Weiner DH: Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of studies of left ventricular dysfunction. J Am Coll Cardiol 1994;23:1410-1420